2025’s biggest healthcare deals
Overall, deals were down in 2025 compared to 2024.
Overall, deals were down in 2025 compared to 2024.
Venture capital firms are focused on technology that enables home care and eases administrative burdens.
Spruce Biosciences saw its stock soar after months of decline, thanks to a new drug for a rare disease.
It may sound simple, but as nonprofit hospitals launch venture arms, the lines become increasingly blurred.
UnitedHealth officially closed its acquisition of Amedisys this month after a federal probe, plus other updates.
Providers are cutting innovation budgets to keep up with Medicaid cuts and tariffs, the investment exec says.
Hospitals are spinning out startups, bringing in new tech and ROI.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.